L-arginine enhances nitrative stress and exacerbates tumor necrosis factor-α toxicity to human endothelial cells in culture: Prevention by propofol

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 4, 2010, Pages 358-367

  Xia, Zhengyuan ^a,b   Luo, Tao ^b   Liu, Hui Min ^a,b   Wang, Fang ^b   Xia, Zhong Yuan ^b   Irwin, Michael G ^a   Vanhoutte, Paul M ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Chonbuk National University   (South Korea)

Author keywords

Apoptosis; L arginine; Nitrative stress; Propofol; Tumor necrosis factor a

Indexed keywords

3 NITROTYROSINE; AMINOGUANIDINE; ARGININE; HYDROGEN PEROXIDE; N (OMEGA) NITRO ARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; PROPOFOL; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3-NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; GLUTATHIONE PEROXIDASE; GUANIDINE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; N(G) NITROARGININE; NITRIC ACID DERIVATIVE; NITRITE; NOS2 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; TYROSINE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NITRATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS;

APOPTOSIS; ARGININE; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GLUTATHIONE PEROXIDASE; GUANIDINES; HUMANS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; MALONDIALDEHYDE; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; NITROARGININE; OXIDATIVE STRESS; PROPOFOL; SUPEROXIDE DISMUTASE; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 77951742414     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181d265a3     Document Type: Article

References (46)

1. Tomasdottir H, Hjartarson H, Ricksten A, et al. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg. 2003;97:944-949.
2. Meldrum DR, Partrick DA, Cleveland JC Jr, et al. On-pump coronary artery bypass surgery activates human myocardial NF-kappaB and increases TNF-alpha in the heart. J Surg Res. 2003;112:175-179.
3. Makino N, Maeda T, Sugano M, et al. High serum TNF-alpha level in type 2 diabetic patients with microangiopathy is associated with eNOS downregulation and apoptosis in endothelial cells. J Diabetes Complications. 2005;19:347-355.
4. Hassanzadeh M, Faridhosseini R, Mahini M, et al. Serum levels of TNF-, IL-6, and selenium in patients with acute and chronic coronary artery disease. Iran J Immunol. 2006;3:142-145.
5. Ohya M, Taniguchi A, Fukushima M, et al. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism. 2005;54:1297-1301.
6. Scarabelli T, Stephanou A, Rayment N, et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation. 2001;104:253-256.
7. Scarabelli TM, Stephanou A, Pasini E, et al. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res. 2002;90:745-748.
8. Amrani M, Chester AH, Jayakumar J, et al. L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res. 1995;30:200-204.
9. Qin Q, Yang XM, Cui L, et al. Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism. Am J Physiol Heart Circ Physiol. 2004;287:H712-H718.
10. Schulz R, Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res. 1995;30:432-439.
11. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/ reperfusion injury. Cardiovasc Res. 2004;61:402-413.
12. Luo T, Xia Z, Ansley DM, et al. Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth Analg. 2005;100:1653-1659.
13. Radomski MW, Vallance P, Whitley G, et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res. 1993;27:1380-1382. (Pubitemid 23250924)
14. Parker JD. Nitrate tolerance, oxidative stress, and mitochondrial function: Another worrisome chapter on the effects of organic nitrates. J Clin Invest. 2004;113:352-354.
15. Kahraman S, Demiryurek AT. Propofol is a peroxynitrite scavenger. Anesth Analg. 1997;84:1127-1129.
16. Mouithys-Mickalad A, Hans P, Deby-Dupont G, et al. Propofol reacts with peroxynitrite to form a phenoxyl radical: demonstration by electron spin resonance. Biochem Biophys Res Commun. 1998;249:833-837.
17. Shelton JL, Wang L, Cepinskas G, et al. Human neutrophil-pulmonary microvascular endothelial cell interactions in vitro: differential effects of nitric oxide vs. peroxynitrite. Microvasc Res. 2008;76:80-88.
18. Uppu RM, Nossaman BD, Greco AJ, et al. Cardiovascular effects of peroxynitrite. Clin Exp Pharmacol Physiol. 2007;34:933-937.
19. Parker JO, Parker JD, Caldwell RW, et al. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy. J Am Coll Cardiol. 2002;39:1199-1203.
20. Schulman SP, Becker LC, Kass DA, et al. L-arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58-64.
21. Liang F, Gao E, Tao L, et al. Critical timing of L-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms. Cardiovasc Res. 2004;62:568-577.
22. Lancaster JR Jr. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol. 2006;19:1160-1174.
23. Dickhout JG, Hossain GS, Pozza LM, et al. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol. 2005; 25:2623-2629.
24. Walford GA, Moussignac RL, Scribner AW, et al. Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitriteinduced activation of mitochondria-dependent and -independent pathways. J Biol Chem. 2004;279:4425-4432.
25. Xia Z, Liu M,Wu Y, et al. N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. Eur J Pharmacol. 2006;550:134-142.
26. Wang F, Liu HM, Irwin MG, et al. Role of protein kinase C beta2 activation in TNF-alpha-induced human vascular endothelial cell apoptosis. Can J Physiol Pharmacol. 2009;87:221-229.
27. Nicoletti I, Migliorati G, Pagliacci MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271-279.
28. Zaugg M, Lucchinetti E, Garcia C, et al. Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth. 2003;91: 566-576. (Pubitemid 37258601)
29. Wu Y, Ouyang JP, Wu K, et al. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats. Br J Pharmacol. 2005;146:234-243.
30. Pearlstein DP, Ali MH, Mungai PT, et al. Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol. 2002;22:566-573.
31. Fink B, Laude K, McCann L, et al. Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol. 2004;287: C895-C902.
32. Vanden Hoek TL, Li C, Shao Z, et al. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol. 1997;29:2571-2583.
33. Cominacini L, Pasini AF, Garbin U, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000;275:12633-12638.
34. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol. 1994; 55:253-258.
35. Yamaoka J, Kabashima K, Kawanishi M, et al. Cytotoxicity of IFNgamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide. Biochem Biophys Res Commun. 2002;291:780-786.
36. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487.
37. Thiry JC, Hans P, Deby-Dupont G, et al. Propofol scavenges reactive oxygen species and inhibits the protein nitration induced by activated polymorphonuclear neutrophils. Eur J Pharmacol. 2004;499:29-33.
38. Huk I, Nanobashvili J, Neumayer C, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/ reperfusion injury in skeletal muscle. Circulation. 1997;96:667-675.
39. Xia Y, Dawson VL, Dawson TM, et al. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A. 1996; 93:6770-6774.
40. Satoh M, Ishikawa Y, Itoh T, et al. The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction. Eur J Clin Invest. 2008;38:97-105.
41. Javanmard SH, Nematbakhsh M, Mahmoodi F, et al. L-Arginine supplementation enhances eNOS expression in experimental model of hypercholesterolemic rabbits aorta. Pathophysiology. 2009;16:9-13.
42. MacKenzie A, Wadsworth RM. Extracellular L-arginine is required for optimal NO synthesis by eNOS and iNOS in the rat mesenteric artery wall. Br J Pharmacol. 2003;139:1487-1497.
43. Chen RM,Wu GJ, Tai YT, et al. Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase. Arch Toxicol. 2003;77: 418-423.
44. Chang H, Tsai SY, Chang Y, et al. Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis. Can J Anaesth. 2002;49:477-480.
45. Li J, Ramenaden ER, Peng J, et al. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. J Neurosci. 2008;28: 5321-5330.
46. Herrick IA, Gelb AW, Nichols B, et al. Patient-controlled propofol sedation for elderly patients: safety and patient attitude toward control. Can J Anaesth. 1996;43:1014-1018.